MedTrace Logo

Comparative Efficacy of an Intensified Re-vaccination Scheme for Hepatitis B Virus Infection Among Patients Infected With HIV .

NCT02003703 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 107

Last updated 2019-01-31

No results posted yet for this study

Summary

Hepatitis B virus infection is a common occurrence among patients with HIV. Effective vaccines are available, but there's some uncertainty regarding specific dosages, specially among those who have not responded to an initial vaccination. The purpose of this study is to determine the effectiveness of a simplified immunization schedule compared to a high-dose one.

Conditions

Interventions

BIOLOGICAL

Recombinant Hepatitis B Virus Vaccine

Sponsors & Collaborators

  • Roche Pharma AG

    collaborator INDUSTRY

  • GlaxoSmithKline

    collaborator INDUSTRY

  • Aclin Laboratory

    collaborator OTHER

  • Universidad de Valparaiso

    lead OTHER

Principal Investigators

  • Francisco Fuster, MD · Hospital Gustavo Fricke, Viña del Mar, Chile

  • Jose I Vargas, MD · Escuela de Medicina, Universidad de Valparaíso, Chile

  • Daniela Jensen, MD · Escuela de Medicina, Universidad de Valparaíso

  • Felipe T Martinez, MD · Centro de Investigaciones Biomédicas, Escuela de Medicina, Universidad de Valparaíso

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2018-06-30
Completion
2018-12-31

Countries

  • Chile

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02003703 on ClinicalTrials.gov